Overview
Lunaphore, a Bio-Techne brand, offers the COMET™ platform for fully automated, high-throughput hyperplex spatial biology, enabling analysis of up to 40 spatial markers per tissue slide using off-the-shelf antibodies. It supports multiplex immunofluorescence, IHC, and multiomics workflows combining RNA and protein detection in the same tissue section for pharma R&D in immuno-oncology, biomarker discovery, and translational research. The platform ensures reproducibility, full tissue preservation, and scalability for clinical trials through partnerships like Discovery Life Sciences.
Frequently asked questions
- What are the key capabilities of Lunaphore's COMET platform?
- COMET provides fully automated hyperplex immunofluorescence for up to 40 markers per slide, multiomics RNA/protein detection, and uses off-the-shelf antibodies with full tissue preservation for downstream analysis.
- Is Lunaphore's technology suitable for clinical research and regulatory compliance?
- Yes, through partnerships like Discovery Life Sciences, COMET supports clinical trials with reproducible, high-throughput spatial profiling for biomarker discovery and patient stratification in immuno-oncology.
- What geographies does Lunaphore serve?
- As a Swiss company and Bio-Techne brand, Lunaphore operates globally, partnering with networks like Discovery Life Sciences for biospecimen and lab services worldwide.